Recent posts

TypePostAuthorRepliesLast updated
Blog entryJune 27-29 USTR NAFTA renegotiation hearings schedule James Love020 min 22 sec ago
Blog entryBrussels Principles on Medication Sales over the Internet Andrew Goldman026 min 24 sec ago
PageZika: Resources on 2016-2017 Army Exclusive Patent License to Sanofi James Love03 hours 9 min ago
Blog entrySave The Date - 5 July 2017 - KEI side event @ WIPO SCP 26 - Compulsory licensing of patents in the United States thiru03 hours 12 min ago
Blog entryHRC35: Human Rights Council adopts Right to Health Resolution thiru010 hours 19 min ago
Blog entrySix Senators Call on Army to Hold Public Hearing on Proposed Exclusive License of Zika Vaccine to Sanofi Andrew Goldman01 day 8 min ago
Blog entryThe Draft Executive Order on Drug prices James Love03 days 7 hours ago
Blog entryDifferences between the march-in, royalty free right, and government use options James Love04 days 2 hours ago
Blog entryHuman Rights Council adopts watershed resolution on Access to Medicines thiru05 days 6 hours ago
Blog entrySpinraza: KEI asks DHHS Office of the Inspector General (OIG) to investigate a failure to disclose federal funding in patents James Love01 week 2 hours ago
Book pageDelinkage James Love01 week 4 hours ago
PageBooks James Love01 week 4 hours ago
PageBayh-Dole Act and difference between March-In Rights and the world wide royalty free rights in patents James Love01 week 9 hours ago
Blog entryComment on proposed Trump Executive Order on drug prices James Love01 week 10 hours ago
Book pagePublications and Research Notes James Love01 week 10 hours ago
Blog entryLexmark: The Supreme Court's patent exhaustion case and parallel trade in drugs James Love01 week 10 hours ago
PageDonate to KEI James Love01 week 10 hours ago
StorySeptember 1999 Letter to NIH, urging it provide the World Health Organization with access to U.S. government-funded medical inventions James Love01 week 1 day ago
Book pageBerne Convention revisions, and the evolution of its limitations and exceptions to copyright James Love01 week 2 days ago
PageThe USTR Special 301 Reports, 1989 to 2017 Anonymous person01 week 3 days ago
Blog entryKEI comments to USTR on the negotiating objectives for the moderation of NAFTA James Love01 week 4 days ago
PageDr. Diane Singhroy, Scientific and Technical Advisor Claire Cassedy01 week 5 days ago
Blog entryFlorida members in House and Senate Object to Proposed Exclusive License of Zika Vaccine KEI Staff01 week 6 days ago
Blog entryJune 2017 - WTO TRIPS Council - Statement of Brazil on IP and the Public Interest - Compulsory Licensing thiru01 week 6 days ago
Blog entryJune 2017 - WTO TRIPS Council - Statement of India on IP and the Public Interest - Compulsory Licensing thiru01 week 6 days ago